Bavarian Nordic A/S (OTCMKTS:BVNRY) Short Interest Up 109.8% in December

Bavarian Nordic A/S (OTCMKTS:BVNRY) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 8,600 shares, an increase of 109.8% from the December 15th total of 4,100 shares. Based on an average daily trading volume, of 27,900 shares, the days-to-cover ratio is presently 0.3 days.

Bavarian Nordic A/S Price Performance

Bavarian Nordic A/S stock traded down $0.36 during midday trading on Wednesday, hitting $8.84. 4,917 shares of the company were exchanged, compared to its average volume of 9,402. The company has a market cap of $2.09 billion, a PE ratio of 12.81 and a beta of 1.65. Bavarian Nordic A/S has a fifty-two week low of $6.86 and a fifty-two week high of $14.60. The company’s fifty day moving average price is $9.06 and its 200-day moving average price is $10.10.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.